Malignancies in transplanted patients: Multidisciplinary evaluation and switch to mTOR inhibitors after kidney transplantation - experiences from a prospective, clinical, observational study.

Conclusion In two thirds of the patients the immunosuppressive treatment could be changed to an mTOR inhibitor with anti-tumor effects in transplanted patients with post-transplant malignancies. The use of regional tumor registers considerably improved the identification of patients with post-transplant malignancies indicating that post-transplant malignancies might be timely underreported in transplant registers.
PMID: 26824275 [PubMed - as supplied by publisher]

Source: Acta Oncologica - January 29, 2016 Category: Cancer & Oncology Authors: Hellström VC, Enström Y, von Zur-Mühlen B, Hagberg H, Laurell A, Nyberg F, Bäckman L, Opelz G, Döhler B, Holmberg L, Tufveson G, Enblad G, Lorant T Tags: Acta Oncol Source Type: research